Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00100919 · ClinicalTrials.gov registry record
Sensing of Leg Position and Movement
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 38
- Enrollment target
NCT00100919: Completed study, sponsored by National Institutes of Health Clinical Center (CC).
NCT00100919 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00100919 has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
This study will collect information on how people sense leg position and movement. The findings may help scientists develop better ways to evaluate and treat joint problems. Healthy adult volunteers between 21 and 40 years of age may be eligible for the study. Candidates are screened with a brief questionnaire and examination to determine their strength, flexibility, and sensation. Participants sit on a specially designed chair, with their foot and leg placed in a custom-made apparatus that controls knee and ankle movements. The skin is marked to indicate the area of interest for ultrasound assessment of muscle. Subjects respond to joint position changes for several trials. The procedure takes a maximum of 2.5 hours to complete. ...
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2005-01-04 |
| Est. Completion | 2010-07-06 |
What the finished NCT00100919 record still lists
NCT00100919 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00100919 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00100919 about?
NCT00100919 is a clinical study titled "Sensing of Leg Position and Movement". This study will collect information on how people sense leg position and movement. The findings may help scientists develop better ways to evaluate and treat joint problems. Healthy adult volunteers between 21 and 40 years of age may be eligible for the study. Candidates are screened with a brief q...
What is the current status of trial NCT00100919?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2005-01-04. Estimated completion is 2010-07-06.
Who is sponsoring clinical trial NCT00100919?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI